M7583 Relative Bioavailability of Tablet Compared to Powder-in-capsule
Clinical trial NCT03297983 · COMPLETED
Trial details
- NCT number
- NCT03297983
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-09
- Primary completion
- 2017-12-06
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.